Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: Percutaneous nephrolithotomy (PCNL) is an effective treatment for large kidney stones, but wider access paths increase the risk of bleeding. While modern miniaturized PCNL techniques reduce invasiveness, they can compromise stone fragment clearance. This study aims to evaluate the efficacy and safety of a novel PCNL technique utilizing pediatric trocar laparoscopy to enhance visualization and potentially minimize blood loss.

Methods: A single-centered prospective study was conducted at Sultan Agung Islamic Hospital, Semarang, Indonesia, between July and September 2024. Patients with large kidney stones underwent a novel technique replacing PCNL after obtaining informed consent. The primary endpoints measured were stone-free rate and major complications after the procedure.

Results: Forty-four participants were enrolled in this study, with 41 completing it. The 24-hour stone-free rate was 87.8%, improving to 100% at 30 days. The mean operative time was 42 ± 13.6 min, with an average hospital stay of 2.39 ± 0.81 days. No major complications were reported. The mean hemoglobin drop was minimal, and transient postoperative leukocytosis without clinical infection was observed.

Conclusion: This study suggests that a novel technique for treating large kidney stones using a 3.5 mm laparoscopic trocar in PCNL is considered an effective and safe procedure as an alternative to the standard PCNL procedure.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-025-05837-5DOI Listing

Publication Analysis

Top Keywords

large kidney
12
kidney stones
12
percutaneous nephrolithotomy
8
laparoscopic trocar
8
novel technique
8
stone-free rate
8
major complications
8
pcnl
6
easy alternative
4
technique
4

Similar Publications

Background: Cardio-kidney-metabolic (CKM) disease represents a significant public health challenge. While proteomics-based risk scores (ProtRS) enhance cardiovascular risk prediction, their utility in improving risk prediction for a composite CKM outcome beyond traditional risk factors remains unknown.

Methods: We analyzed 23 815 UK Biobank participants without baseline CKM disease, defined by -Tenth Revision codes as cardiovascular disease (coronary artery disease, heart failure, stroke, peripheral arterial disease, atrial fibrillation/flutter), kidney disease (chronic kidney disease or end-stage renal disease), or metabolic disease (type 2 diabetes or obesity).

View Article and Find Full Text PDF

Chronic kidney disease (CKD), heart failure (HF) and atherosclerotic cardiovascular disease (ASCVD) are pathologies that may remain silent for a long time and thus are largely underdiagnosed in clinical practice. The use of biomarkers may help detect people already suffering from these diseases at an early stage or at increased risk to develop them in a near future. The aim of this article is to discuss the place of the assays of albuminuria, natriuretic peptide (BNP/proBNP) and high-sensitivity troponin as well as lipoprotein(a) to help in the diagnosis and prognosis assessment of individuals at risk of presenting or developing a CKD, HF or ASCVD.

View Article and Find Full Text PDF

PATJ deficiency leads to cystic kidney disease and related ciliopathies.

HGG Adv

September 2025

Department of Medicine IV, Faculty of Medicine, Medical Center-University of Freiburg, University of Freiburg, Freiburg, Germany; Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany. Electronic address:

Cystic kidney disease and related ciliopathies are caused by pathogenic variants in genes that commonly result in ciliary dysfunction. For a substantial number of individuals affected by those cilia-related diseases, the causative gene still remains unknown. Using massively parallel sequencing, we here identified a pathogenic bi-allelic variant in the gene encoding PALS1-Associated Tight Junction Protein (PATJ; also known as Inactivation-No-Afterpotential D-Like, INADL) in an individual with ciliopathy.

View Article and Find Full Text PDF

Objective: Determine whether acute kidney injury (AKI) is associated with subsequent late-onset infection (LOI) among extremely low gestational age newborns (ELGAN).

Study Design: Secondary analysis of participants in the Preterm Erythropoietin for Neuroprotection Trial. Infants surviving ≥7 days with sufficient serum creatinine data were included.

View Article and Find Full Text PDF

Negative regulation of the IL-4/13-mediated Th2 immune response by microRNA-126b via targeting IL-4Rα1 in large yellow croaker (Larimichthys crocea).

Fish Shellfish Immunol

September 2025

College of Marine Sciences, State Key Laboratory of Mariculture Breeding, Key Laboratory of Marine Biotechnology of Fujian Province, College of Life Science, Fujian Agriculture and Forestry University, Fuzhou, 350002, China; Laboratory for Marine Biology and Biotechnology, Qingdao Marine Science and

The closely related cytokines Interleukin-4 (IL-4) and IL-13 regulate the Th2 immune response by interacting with their specific receptor complexes. MicroRNAs (miRNAs) modulate various biological pathways through mechanisms that either repress mRNA translation or promote messenger RNA degradation. The miRNA miR-126b is implicated in fish embryonic development.

View Article and Find Full Text PDF